Related Experiment Video
Updated: Aug 21, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Enhanced macrophage antitumor effects of protein A in combination with IFN-gamma
Abstract:
In this study we examined the potential for the synergistic augmentation of the antitumor activity of inflammatory mouse peritoneal macrophages by stimulation with protein A combined with IFN-gamma. The moderate augmentative effect induced by preincubation with protein A was demonstrated to be concentration-dependent, whereas IFN-gamma had a very low activating effect. Following preincubation with both protein A and IFN-gamma, a marked enhancement of macrophage activity was noted. In addition, based on the utilization of neutralizing antibody to TNF-alpha or the inhibition of NO production, TNF-alpha and NO were proven to be involved as mediators during the activation of tumoricidal macrophages by protein A in combination with IFN-gamma. We also demonstrated that supernatants from macrophages treated with protein A plus IFN-gamma contained both TNF-alpha and NO at markedly increased levels. Thus, tumor cell lysis in the combined system was mediated via TNF-alpha or NO. These results demonstrate the synergistic effects on mouse peritoneal macrophage function of protein A in combination with IFN-gamma and suggest that combinations of such agents may serve as the basis for future in vivo immunotherapy.
Insights
Combining protein A and interferon-gamma synergistically enhances antitumor macrophage activity. Tumor cell lysis is mediated by tumor necrosis factor-alpha and nitric oxide, suggesting potential for novel immunotherapy.
Area of Science:
- Immunology
- Cancer Biology
- Biotherapy
Background:
- Inflammatory mouse peritoneal macrophages play a role in antitumor responses.
- Protein A and Interferon-gamma (IFN-γ) are known immunomodulators.
- Investigating synergistic effects of combined immunotherapies is crucial for cancer treatment.
Purpose of the Study:
- To evaluate the synergistic effect of protein A and IFN-γ on the antitumor activity of mouse peritoneal macrophages.
- To identify the key mediators involved in the enhanced macrophage activity.
Main Methods:
- Macrophages were preincubated with varying concentrations of protein A and/or IFN-γ.
- Antitumor activity was assessed by measuring macrophage-mediated tumor cell lysis.
- Neutralizing antibodies against tumor necrosis factor-alpha (TNF-α) and nitric oxide (NO) production inhibition were used to determine mediator involvement.
Main Results:
- Protein A showed a concentration-dependent moderate augmentation of macrophage activity.
- IFN-γ alone had a minimal activating effect.
- Combined preincubation with protein A and IFN-γ resulted in markedly enhanced macrophage activity and tumoricidal function.
- TNF-α and NO were identified as critical mediators in the synergistic activation, with increased levels observed in supernatants.
Conclusions:
- Protein A and IFN-γ exhibit synergistic effects in enhancing mouse peritoneal macrophage antitumor activity.
- The combined therapy's efficacy is mediated through TNF-α and NO.
- These findings suggest a potential basis for developing combined immunotherapeutic strategies for in vivo cancer treatment.

